Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
4/24/25 17:38 | 4/22/25 | PASG | Health | BioPrd | Biological Products, (No Diag | Orbimed Advisors LLC | NY | T | 9 | S.m | -816 | 0.5897 | 0 | -1,384 | 7,834 | I | ||||||||||||||||
2/12/25 16:21 | 2/11/25 | PASG | Health | BioPrd | Biological Products, (No Diag | Borthwick Kathleen | PA | O | CFO | 2 | S.d | -3 | 0.6688 | 0 | -5 | 41 | D | |||||||||||||||
2/13/24 19:34 | 2/13/24 | PASG | Health | BioPrd | Biological Products, (No Diag | Forman Mark S | PA | O | Chief Me | 1 | S.d | -2 | 0.9701 | 0 | -2 | 49 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |